Literature DB >> 2998561

Low doses of ethanol activate dopaminergic neurons in the ventral tegmental area.

G L Gessa, F Muntoni, M Collu, L Vargiu, G Mereu.   

Abstract

In unanesthetized rats the intravenous administration of low doses of ethanol (0.125-0.5 g/kg) produced a dose-dependent increase (30-80%) in the firing rate of dopaminergic (DA) neurons in the Ventral Tegmental Area (VTA). In agreement with previous observations, a dose range between 0.5 and 2 g/mg of ethanol was needed to produce comparable stimulant responses in DA neurons of the Substantia Nigra Pars Compacta. However, in anesthetized rats, doses of ethanol up to 1 g/kg failed to activate VTA-DA neurons. The high sensitivity of VTA-DA neurons to ethanol activation suggests that they might be involved in the reinforcing properties of the drug.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2998561     DOI: 10.1016/0006-8993(85)90381-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  171 in total

1.  GABAergic actions mediate opposite ethanol effects on dopaminergic neurons in the anterior and posterior ventral tegmental area.

Authors:  Yanzhong Guan; Cheng Xiao; Kresimir Krnjevic; Guiqin Xie; Wanhong Zuo; Jiang-Hong Ye
Journal:  J Pharmacol Exp Ther       Date:  2011-12-30       Impact factor: 4.030

2.  Effects of A₂A adenosine receptor blockade or stimulation on alcohol intake in alcohol-preferring rats.

Authors:  Maria Vittoria Micioni Di Bonaventura; Carlo Cifani; Catia Lambertucci; Rosaria Volpini; Gloria Cristalli; Rino Froldi; Maurizio Massi
Journal:  Psychopharmacology (Berl)       Date:  2011-08-11       Impact factor: 4.530

Review 3.  The relationship of appetitive, reproductive and posterior pituitary hormones to alcoholism and craving in humans.

Authors:  George A Kenna; Robert M Swift; Thomas Hillemacher; Lorenzo Leggio
Journal:  Neuropsychol Rev       Date:  2012-07-07       Impact factor: 7.444

Review 4.  Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models.

Authors:  Megan M Yardley; Lara A Ray
Journal:  Addict Biol       Date:  2016-02-01       Impact factor: 4.280

5.  Positive Emotion Regulation and Psychopathology: A Transdiagnostic Cultural Neuroscience Approach.

Authors:  Lisa A Hechtman; Hannah Raila; Joan Y Chiao; June Gruber
Journal:  J Exp Psychopathol       Date:  2013-05-13

6.  Mechanistic insights into epigenetic modulation of ethanol consumption.

Authors:  Igor Ponomarev; Claire E Stelly; Hitoshi Morikawa; Yuri A Blednov; R Dayne Mayfield; R Adron Harris
Journal:  Alcohol       Date:  2017-03-12       Impact factor: 2.405

7.  Prolonged increase in the sensitivity of the posterior ventral tegmental area to the reinforcing effects of ethanol following repeated exposure to cycles of ethanol access and deprivation.

Authors:  Zachary A Rodd; Richard L Bell; Victoria K McQueen; Michelle R Davids; Cathleen C Hsu; James M Murphy; Ting-Kai Li; Lawrence Lumeng; William J McBride
Journal:  J Pharmacol Exp Ther       Date:  2005-08-02       Impact factor: 4.030

8.  Acute and chronic ethanol modulate dopamine D2-subtype receptor responses in ventral tegmental area GABA neurons.

Authors:  Kimberly H Ludlow; Katie D Bradley; David W Allison; Seth R Taylor; Jordan T Yorgason; David M Hansen; Christine H Walton; Sterling N Sudweeks; Scott C Steffensen
Journal:  Alcohol Clin Exp Res       Date:  2009-03-06       Impact factor: 3.455

9.  Analysis of the biphasic locomotor response to ethanol in high and low responders to novelty: a study in Nijmegen Wistar rats.

Authors:  M A Gingras; A R Cools
Journal:  Psychopharmacology (Berl)       Date:  1996-06       Impact factor: 4.530

10.  Contingent and non-contingent effects of low-dose ethanol on GABA neuron activity in the ventral tegmental area.

Authors:  Scott C Steffensen; Christine H Walton; David M Hansen; Jordan T Yorgason; Roger A Gallegos; Jose R Criado
Journal:  Pharmacol Biochem Behav       Date:  2008-10-29       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.